Showing 1 - 1 of 1 Diabetes %26 Insulin Disorders
A Multicenter, Randomized, Double-blind, Sham-controlled study for Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals with Type II Diabetes

Status: Open Not Enrolling

Investigator: Abhishek Kansara

Study Coordinator: Michelle Nguyen

Phone: 346.238.4586

This research study is designed to evaluate the safety and effectiveness of the ReCET™ device for improving glycemic (blood sugar) control in individuals with T2D. This study plans to enroll a minimum of 264 and a maximum of 350 participants ... Read more >